Upgrade to SI Premium - Free Trial

Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $21 at Mizuho, 'a current top pick'

April 28, 2026 6:35 AM
Mizuho analyst Graig Suvannavejh raised the price target on Amylyx Pharmaceuticals inc. (NASDAQ: AMLX) to $21.00 (from $19.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change